Amedeo Smart

Free Medical Literature Service

 

Amedeo

Malignant Lymphoma
  Free Subscription

Articles published in
Proc Natl Acad Sci U S A
    August 2025
  1. HUANG Y, Lin H, Shi J, Chen Y, et al
    Serum metabolic patterns reveal the diagnostic and prognostic role of alanine abnormality in ocular adnexal lymphoma.
    Proc Natl Acad Sci U S A. 2025;122:e2506345122.
    >> Share

    June 2025
  2. ZHANG N, Seo JW, Robinson E, Rivera-Rodriguez A, et al
    Development of an in situ CAR-T cell protocol through optical and PSMA-targeted PET imaging.
    Proc Natl Acad Sci U S A. 2025;122:e2504950122.
    >> Share

    April 2025
  3. TILI E, Commisso TL, Balatti V, Michaille JJ, et al
    miR-155 impairs ICOSL and MHC-I expression in DLBCL lymphomas.
    Proc Natl Acad Sci U S A. 2025;122:e2422615122.
    >> Share

    December 2024
  4. CERIBELLI M, Tosto FA, Zhang X, Melani CJ, et al
    Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicity.
    Proc Natl Acad Sci U S A. 2024;121:e2413372121.
    >> Share

    July 2024
  5. ZHONG X, Moresco JJ, SoRelle JA, Song R, et al
    Disruption of the ZFP574-THAP12 complex suppresses B cell malignancies in mice.
    Proc Natl Acad Sci U S A. 2024;121:e2409232121.
    >> Share

    April 2024
  6. LI MY, Chong LC, Duns G, Lytle A, et al
    TRAF3 loss-of-function reveals the noncanonical NF-kappaB pathway as a therapeutic target in diffuse large B cell lymphoma.
    Proc Natl Acad Sci U S A. 2024;121:e2320421121.
    >> Share

  7. MAROUI MA, Odongo GA, Mundo L, Manara F, et al
    Aflatoxin B1 and Epstein-Barr virus-induced CCL22 expression stimulates B cell infection.
    Proc Natl Acad Sci U S A. 2024;121:e2314426121.
    >> Share

  8. KRISTENSON L, Badami C, Ljungberg A, Islamagic E, et al
    Deletion of the TMEM30A gene enables leukemic cell evasion of NK cell cytotoxicity.
    Proc Natl Acad Sci U S A. 2024;121:e2316447121.
    >> Share

    March 2024
  9. MA J, Al Moussawi K, Lou H, Chan HF, et al
    Deficiency of factor-inhibiting HIF creates a tumor-promoting immune microenvironment.
    Proc Natl Acad Sci U S A. 2024;121:e2309957121.
    >> Share

    January 2024

  10. Correction for Scuoppo et al., Repurposing dasatinib for diffuse large B cell lymphoma.
    Proc Natl Acad Sci U S A. 2024;121:e2321988121.
    >> Share

    December 2023
  11. JUILLAND M, Alouche N, Ubezzi I, Gonzalez M, et al
    Identification of Tensin-3 as a MALT1 substrate that controls B cell adhesion and lymphoma dissemination.
    Proc Natl Acad Sci U S A. 2023;120:e2301155120.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016